In the article by El-Haggar et al. entitled “The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial” [Psychother Psychosom. 2018;87(6):331–9, DOI: 10.1159/000492619], there was an unintentional error in reporting the statistical value in Table 1 and Table 4. By mistake, we reported the F value of Levene’s Test for Equality of Variances instead of the t statistics for age, weight, height, and BMI and the incorrect df was reported for all t test results except HAM-D score. The use of the χ2 test was inappropriate in the article as the assumption that all cells will have an expected value of >5 was not met in many tests. As a result, the Fisher’s exact test was used for categorical data. The error occurred inadvertently during the manuscript preparation.
This unintentional error has no bearing on our study’s findings or conclusions as the p value is still p > 0.5, which is not statistically significant.
An expert biostatistician used valid tests to conduct each analysis, which was then revised by all the authors. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The corrected Table 1 and Table 4 are shown here.
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
